Pharmacological Targeting of the Hsp70 Chaperone

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|15|1337-1351

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.15, 2009-11, pp. : 1337-1351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Hsp90-Cdc37: A Promising Therapeutic Strategy by Inhibiting Hsp90 Chaperone Function

By  

Current Drug Targets, Vol. 18, Iss. 13, 2017-09 ,pp. : 1572-1585

Bentham Science Publishers

Access to resources Recommend Favorite

Lysosomal Rerouting of Hsp70 Trafficking as a Potential Immune Activating Tool for Targeting Melanoma

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 430-440

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Chaperone Disorders: Defective Hsp60 in Neurodegeneration

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 22, 2012-11 ,pp. : 2491-2503

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological chaperone therapy for Gaucher disease: a patent review

By Benito Juan M   Garcíía Fernáández Joséé M   Mellet Carmen Ortiz  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 885-903

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Targeting of the Epidermal Barrier

By  

Current Pharmaceutical Design, Vol. 22, Iss. 35, 2016-11 ,pp. : 5373-5381

Bentham Science Publishers

Access to resources Recommend Favorite